EE670 Management Costs of Grade 3/4 Adverse Events Associated with Emerging and Existing Systemic Therapies for Metastatic Colorectal Cancer with at Least Two Prior Lines of Therapy in Italy, Portugal, Spain, and the United States
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.935
https://www.valueinhealthjournal.com/article/S1098-3015(23)04065-2/fulltext
Title :
EE670 Management Costs of Grade 3/4 Adverse Events Associated with Emerging and Existing Systemic Therapies for Metastatic Colorectal Cancer with at Least Two Prior Lines of Therapy in Italy, Portugal, Spain, and the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04065-2&doi=10.1016/j.jval.2023.09.935
First page :
Section Title :
Open access? :
No
Section Order :
10428